Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 28.9.2026Gedeon Richter Plc. (GDN)86922Ossica 150 mg filmom obalené tablety (tbl flm 3x150 mg (blis.PVC/PE/PVDC/Al))25.9.2026R
 28.9.2026Teva B.V. (TEV-NL-4)34950MEGESIN 160 mg (tbl 100x160 mg)30.11.2026Z
 28.9.2026Teva B.V. (TEV-NL-4)1705ELonquex 6 mg/0,6 ml injekčný roztok (sol inj 6x0,6 ml/6 mg (liek.inj.skl.))28.9.2026Z
 28.9.2026STADA Arzneimittel AG (STD)7308ENilotinib STADA 200 mg tvrdé kapsuly (cps dur 112 (4x28)x200 mg (blis.PVC/PE/PVDC/Al)-multibal.)31.12.2026Z
 28.9.2026STADA Arzneimittel AG (STD)7280ENilotinib STADA 150 mg tvrdé kapsuly (cps dur 112 (4x28)x150 mg (blis.PVC/PE/PVDC/Al)-multibal.)31.12.2026Z
 27.9.2026Actavis Group PTC ehf. (ACT-10)12098Levetiracetam Actavis 500 mg filmom obalené tablety (tbl flm 100x500 mg (blis.Al/PVC))18.10.2026R
 27.9.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)84127HERPESIN 200 (tbl 25x200 mg (blis.PVC/Al))16.9.2026O
 27.9.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)68676Escitalopram Teva 10 mg (tbl flm 90x10 mg (blis.PVC/PVDC/Al))10.11.2026R
 27.9.2026Teva B.V. (TEV-NL-4)90396Carvedilol-Teva 12,5 mg (tbl 28x12,5 mg (blis.PVC/PVDC/Al))22.9.2026U
 27.9.2026Teva B.V. (TEV-NL-4)0055FGabapentin Teva B.V. 100 mg (cps dur 100x100 mg (blis.PVC/PVdC//Al))25.9.2026O
 27.9.2026ratiopharm GmbH (RAT)85147Ratiograstim 48 MIU/0,8 ml injekčný alebo infúzny roztok (sol ijf 5x0,8 ml/480 µg (48 MIU) (striek.skl.napln. s bezp.zar.))25.9.2026O
 27.9.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)7093DLOGNIF 0,5 mg tvrdé kapsuly (cps dur 28x1x0,5 mg (blis.OPA/Al/PVC/Al-jednotliv.dáv.))25.9.2026O
 27.9.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)8596DPaliperidón Teva 75 mg injekčná suspenzia s predĺženým uvoľňovaním (sus ijp 1x75 mg (striek.inj.napln.+2x ihla))25.9.2026O
 25.9.2026Norgine B.V. (NGN-NL-1)04241MOVIPREP (plo por 1x(2x112 g+2x11g) (vre.Al/LDPE/papier))25.9.2026R
 25.9.2026Norgine B.V. (NGN-NL-1)7161CPlenvu (plo por 1x3 vrecká PET/Al/extrud.živica (1.dávka + 2.dávka A+B))25.9.2026R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)